These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1591733

  • 1. Increased accumulation of drugs in multidrug-resistant cells induced by liposomes.
    Warren L, Jardillier JC, Malarska A, Akeli MG.
    Cancer Res; 1992 Jun 01; 52(11):3241-5. PubMed ID: 1591733
    [Abstract] [Full Text] [Related]

  • 2. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT, Cirtain MC, Lefko JL.
    Mol Pharmacol; 1983 Nov 01; 24(3):485-92. PubMed ID: 6579344
    [Abstract] [Full Text] [Related]

  • 3. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L, Jardillier JC, Ordentlich P.
    Cancer Res; 1991 Apr 15; 51(8):1996-2001. PubMed ID: 1672622
    [Abstract] [Full Text] [Related]

  • 4. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.
    Beck WT, Cirtain MC.
    Cancer Res; 1982 Jan 15; 42(1):184-9. PubMed ID: 7198507
    [Abstract] [Full Text] [Related]

  • 5. Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells.
    Colin M, Madoulet C, Baccard N, Arsac F, Jardillier JC.
    Anticancer Res; 1994 Jan 15; 14(6A):2383-7. PubMed ID: 7825977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 15; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 8. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB, Beck WT, Trent JM.
    Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 10. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE, Janowska-Wieczorek A, Lynch MA, Sheinin H, Hindenburg AA, Beck WT.
    Cancer Res; 1989 Nov 01; 49(21):5798-804. PubMed ID: 2790792
    [Abstract] [Full Text] [Related]

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
    Shu Y, Liu H.
    Biochem Cell Biol; 2007 Oct 01; 85(5):638-46. PubMed ID: 17901905
    [Abstract] [Full Text] [Related]

  • 12. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW.
    Cancer Res; 1989 Oct 01; 49(19):5281-7. PubMed ID: 2569932
    [Abstract] [Full Text] [Related]

  • 13. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman AW, Rigal D, Baggetto LG.
    Biochemistry; 2005 Mar 22; 44(11):4499-509. PubMed ID: 15766280
    [Abstract] [Full Text] [Related]

  • 14. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
    Bosch I, Dunussi-Joannopoulos K, Wu RL, Furlong ST, Croop J.
    Biochemistry; 1997 May 13; 36(19):5685-94. PubMed ID: 9153408
    [Abstract] [Full Text] [Related]

  • 15. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT, Sharma R, Grady JJ, Awasthi S.
    Drug Metab Dispos; 2001 Feb 13; 29(2):103-10. PubMed ID: 11159798
    [Abstract] [Full Text] [Related]

  • 16. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M, Morris MB, Roufogalis BD.
    Br J Cancer; 2001 Dec 14; 85(12):1998-2003. PubMed ID: 11747345
    [Abstract] [Full Text] [Related]

  • 17. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H, Niethammer D, Jackson RC.
    Cancer Res; 1983 Nov 14; 43(11):5286-92. PubMed ID: 6225514
    [Abstract] [Full Text] [Related]

  • 18. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

  • 19. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M, Madafiglio J, Norris MD, Haber M.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):79-85. PubMed ID: 8093660
    [Abstract] [Full Text] [Related]

  • 20. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.
    Clin Cancer Res; 2000 May 15; 6(5):1949-57. PubMed ID: 10815920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.